Organisation paid for research Program year 2022 Source: CMS Open Payments

Bidmc

Neither a doctor nor a teaching hospital

Research payments

$551

7 payments

Through program year 2022, Bidmc is reported as receiving $551 in research payments, across 7 payments.

By program year

3 rows

Year	Kind	Amount	Payments
2022	Research	$140	3
2021	Research	$210	3
2020	Research	$201	1

Breakdown

Who paid Research payments · program years 2020–2022

Biohaven Pharmaceuticals, Inc. $210 3 payments
Amgen Inc. $201 1 payment
Biohaven Pharmaceutical Holding Company Ltd. $140 3 payments

Studies the money was for Research payments · program years 2020–2022

A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects With Multiple System Atrophy (M-STAR Study) $210 3 payments
LCM:A Phase 3 Randomized Placebo Controlled Study of the Treatment of CIT for Solid Tumors- Study 1 $201 1 payment
A Randomized Double-Blind Placebo-Controlled Parallel- Group Study to Evaluate the Efficacy and Safety of BHV-3241 in Subjects With Multiple System Atrophy (M-STAR Study) $140 3 payments

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.